comparemela.com
Home
Live Updates
J&J slashes production of its unpopular COVID-19 shot : comparemela.com
J&J slashes production of its unpopular COVID-19 shot
A partnership with rival Merck & Co. to help make the shots, forged at the urging of the U.S. government, hasn’t lived up to expectations. The companies are now engaged in arbitration.
Related Keywords
Germany ,
Pennsylvania ,
United States ,
Tennessee ,
India ,
Spain ,
France ,
West Point ,
French ,
Mark Green ,
Biologika Gmb ,
Prashant Yadav ,
Laboratorio Reig Jofre ,
Stavros Nicolaou ,
Remo Colarusso ,
Reig Jofre ,
Centers For Disease ,
Global Development ,
E Limited Of India ,
Emergent Biosolutions Inc ,
Merck Co ,
Africa Aspen Pharmacare Holdings Ltd ,
Pfizer ,
Pfizer Inc ,
Catalent Inc ,
Moderna Inc ,
Johnson ,
Evening Edit ,
New Brunswick ,
Disease Control ,
Defense Production Act ,
Aspen Pharmacare Holdings ,
comparemela.com © 2020. All Rights Reserved.